GenFleet Therapeutics Executes HKD 1.96 Million Share Buyback, Lifts Treasury Stock to 191,000 Shares

Bulletin Express

Yesterday

GenFleet Therapeutics (GENFLEET-B) disclosed a repurchase of 75,000 H-shares on 9 September 2026, spending HKD 1.96 million at prices between HKD 25.72 and HKD 26.76 per share. The volume-weighted average purchase price was HKD 26.14.

Following the transaction, issued shares outstanding (excluding treasury shares) fell 0.02 % to 351.44 million, while treasury shares rose to 191,000. Total issued shares remain unchanged at 351.63 million, as the bought-back shares are being retained as treasury stock.

The buyback forms part of a mandate approved on 11 May 2026 authorising the company to repurchase up to 37.04 million shares. Cumulative repurchases under this mandate now stand at 191,000 shares, equivalent to 0.05 % of the share count at the mandate date.

In line with Hong Kong Stock Exchange rules, GenFleet is restricted from issuing, selling or transferring shares for 30 days following the repurchase, placing the moratorium period through 9 October 2026. The company confirmed all regulatory requirements and listing rules were observed during the transaction.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/news/1142170459"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1142170459\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1142170459?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-09 20:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142170459","market":"us","top_or_hot":-1,"title":"GenFleet Therapeutics Executes HKD 1.96 Million Share Buyback, Lifts Treasury Stock to 191,000 Shares","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (GENFLEET-B) disclosed a repurchase of 75,000 H-shares on 9 September 2026, spending HKD 1.96 million at prices between HKD 25.72 and HKD 26.76 per share. The volume-weighted average purchase price was HKD 26.14.</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) fell 0.02 % to 351.44 million, while treasury shares rose to 191,000. Total issued shares remain unchanged at 351.63 million, as the bought-back shares are being retained as treasury stock.</p>\n<p>The buyback forms part of a mandate approved on 11 May 2026 authorising the company to repurchase up to 37.04 million shares. Cumulative repurchases under this mandate now stand at 191,000 shares, equivalent to 0.05 % of the share count at the mandate date.</p>\n<p>In line with Hong Kong Stock Exchange rules, GenFleet is restricted from issuing, selling or transferring shares for 30 days following the repurchase, placing the moratorium period through 9 October 2026. The company confirmed all regulatory requirements and listing rules were observed during the transaction.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Executes HKD 1.96 Million Share Buyback, Lifts Treasury Stock to 191,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Executes HKD 1.96 Million Share Buyback, Lifts Treasury Stock to 191,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-09 20:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (GENFLEET-B) disclosed a repurchase of 75,000 H-shares on 9 September 2026, spending HKD 1.96 million at prices between HKD 25.72 and HKD 26.76 per share. The volume-weighted average purchase price was HKD 26.14.</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) fell 0.02 % to 351.44 million, while treasury shares rose to 191,000. Total issued shares remain unchanged at 351.63 million, as the bought-back shares are being retained as treasury stock.</p>\n<p>The buyback forms part of a mandate approved on 11 May 2026 authorising the company to repurchase up to 37.04 million shares. Cumulative repurchases under this mandate now stand at 191,000 shares, equivalent to 0.05 % of the share count at the mandate date.</p>\n<p>In line with Hong Kong Stock Exchange rules, GenFleet is restricted from issuing, selling or transferring shares for 30 days following the repurchase, placing the moratorium period through 9 October 2026. The company confirmed all regulatory requirements and listing rules were observed during the transaction.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1142170459","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142170459","pubTimestamp":1788956506,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (GENFLEET-B) disclosed a repurchase of 75,000 H-shares on 9 September 2026, spending HKD 1.96 million at prices between HKD 25.72 and HKD 26.76 per share. The volume-weighted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics 执行 196 万港元股票回购，库存股增至 191,000 股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (GENFLEET-B) disclosed a repurchase of 75,000 H-shares on 9 September 2026, spending HKD 1.96 million at prices between HKD 25.72 and HKD 26.76 per share. The volume-weighted average purchase price was HKD 26.14.\nFollowing the transaction, issued shares outstanding (excluding treasury shares) fell 0.02 % to 351.44 million, while treasury shares rose to 191,000. Total issued shares remain unchanged at 351.63 million, as the bought-back shares are being retained as treasury stock.\nThe buyback forms part of a mandate approved on 11 May 2026 authorising the company to repurchase up to 37.04 million shares. Cumulative repurchases under this mandate now stand at 191,000 shares, equivalent to 0.05 % of the share count at the mandate date.\nIn line with Hong Kong Stock Exchange rules, GenFleet is restricted from issuing, selling or transferring shares for 30 days following the repurchase, placing the moratorium period through 9 October 2026. The company confirmed all regulatory requirements and listing rules were observed during the transaction.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}